Solutions by Modality

Conjugated Drugs

We provide comprehensive preclinical services for ADCs (Antibody-Drug Conjugates), covering efficacy evaluation, toxicology studies, and pharmacological profiling. ADCs combine the target specificity of antibodies with the cytotoxicity of drugs, requiring precise and systematic preclinical assessments.

Key Services

  • Efficacy studies: Target-specific cytotoxicity and tumor suppression analysis
  • PK/distribution studies: Evaluation of in vivo drug distribution and plasma half-life
  • Toxicity studies: Assessment of toxicity and safety for major organs

Highlights

  • IND-enabling ADC preclinical packages
  • Data aligned with global regulatory requirements
  • Extensive experience across diverse ADC platforms